Neurology Central

Expert Panelist: Alberto Espay


Alberto Espay

Associate Professor of Neurology, Director, James J. and Joan A. Gardner Family Center Research Chair for Parkinson’s Disease and Movement Disorders (University of Cincinnati, OH, USA)

Dr. Alberto Espay is the director, associate professor and endowed chair of the University of Cincinnati James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders (OH, USA).

After neurology training at Indiana University, he completed his clinical and electrophysiology training in Movement Disorders as well as an MSc program in Clinical Epidemiology and Health Care Research (Toronto Western Hospital, University of Toronto, Canada). He has published over 120 peer-reviewed research articles and five books, including Common Movement Disorders Pitfalls (Cambridge, Highly Commended BMA Medical Book Award, 2013) and Disorders of Movement (Springer, 2016). Dr. Espay has received the Dean’s Scholar in Clinical Research Award (2006-09), the Dystonia Coalition Career Development Award (2010-2012), the NIH-funded KL2 Research Scholars Mentored Award (2010-12), and the NIH-funded K23 Career Development Award (2011–17).

He currently serves as Chair of the Technology Task Force, Chair of the Membership and Public Relations Committee of the International Parkinson and Movement Disorders Society, and Executive Committee member of the Parkinson Study Group. He is former Chair of the Movement Disorders Section of the American Academy of Neurology and former Associate Editor of Movement Disorders. He became honorary member of the Mexican Academy of Neurology in 2008, has been on the Best Doctors in America list since 2009, and has received several awards including the Business Courier’s Forty Under 40 award in 2010, the Patients’ Choice and Compassionate Doctor awards in 2011, the Cincinnati Business Courier’s Health Care Hero Award in 2016, and the Spanish Society of Neurology’s Cotzias Award in 2016. His research efforts have focused on the measurements of motor and behavioral phenomena and clinical trials for Parkinson disease.

View the rest of our Expert Panel here